REQUEST A DEMO
Total
USD $0.00
Search more companies

Pharmatrade, Spol. S R.O. (Czech Republic)

Main Activities: Chemical Manufacturing
Full name: Pharmatrade, Spol. S R.O. Profile Updated: October 13, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Pharmatrade, Spol. S R.O. is an enterprise located in Czech Republic, with the main office in Prague. The enterprise currently operates in the Chemical Manufacturing sector. Pharmatrade, Spol. S R.O. was incorporated on October 08, 1992. It currently has a total number of 1 - 5 (2023) employees. There was a net sales revenue drop of 94.64% reported in Pharmatrade, Spol. S R.O.’s latest financial highlights for 2025. During that time, Pharmatrade, Spol. S R.O.’s total assets decreased by 36.23%. The enterprise’s net profit margin decreased by 19510.2% in 2025.

Headquarters
Jihozapadni IV 1116/11
Prague; The City of Prague; Postal Code: 14100

Contact Details: Purchase the Pharmatrade, Spol. S R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Pharmatrade, Spol. S R.O. report to view the information.
Registered Capital:
Purchase the Pharmatrade, Spol. S R.O. report to view the information.
Financial Auditors:
Purchase the Pharmatrade, Spol. S R.O. report to view the information.
Incorporation Date:
October 08, 1992
Key Executives
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Pharmatrade, Spol. S R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
-94.64%▼
Total Operating Revenue
-96.65%▼
Operating Profit
36.71%▲
EBITDA
38.33%▲
Net Profit/Loss for the Period
34.92%▲
Total Assets
-36.23%▼
Total Equity
-36.38%▼
Operating Profit Margin
-18925.58%▼
Net Profit Margin
-19510.2%▼
Return on Equity (ROE)
-1.28%▼

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?